Document:

EXHIBIT 10.3

THIS WARRANT AND THE  SECURITIES  ISSUABLE  HEREUNDER  HAVE NOT BEEN  REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS. THEY
MAY NOT BE SOLD,  OFFERED  FOR SALE,  PLEDGED OR  OTHERWISE  TRANSFERRED  IN THE
ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT AND ANY APPLICABLE
STATE  SECURITIES  LAWS OR THE  AVAILABILITY  OF AN EXEMPTION FROM  REGISTRATION
UNDER SUCH ACT AND ANY APPLICABLE STATE SECURITIES LAWS.

                        WARRANT TO PURCHASE COMMON STOCK

       NUMBER OF SHARES:          Up to 119,565 shares (subject to adjustment)
       WARRANT PRICE:             $0.92 per share
       ISSUANCE DATE:             January 18, 2005
       EXPIRATION DATE:           January 18, 2008
THIS WARRANT CERTIFIES THAT for value received, Mercator Advisory Group, LLC or
its registered assigns (hereinafter called the "HOLDER") is entitled to purchase
from GeneThera, Inc. (hereinafter called the "Company"), the above referenced
number of fully paid and nonassessable shares (the "SHARES") of common stock
(the "COMMON STOCK"), of Company, at the Warrant Price per Share referenced
above; the number of shares purchasable upon exercise of this Warrant referenced
above being subject to adjustment from time to time as described herein. This
Warrant is issued in connection with that certain Subscription Agreement dated
as of the date hereof, by and between the Company and Holder (the "SUBSCRIPTION
AGREEMENT"). The exercise of this Warrant shall be subject to the provisions,
limitations and restrictions contained herein.

1. TERM AND EXERCISE.

1.1 TERM. This Warrant is exercisable in whole or in part (but not as to any
fractional share of Common Stock), at any time and from time to time after the
date hereof prior to 6:00 p.m. on the Expiration Date set forth above.

1.2  WARRANT  PRICE.  The Warrant  shall be  exercisable  at the  Warrant  Price
described above.

1.3  MAXIMUM  NUMBER OF SHARES.  The  maximum  number of Shares of Common  Stock
exercisable pursuant to this Warrant is 119.565 Shares. However, notwithstanding
anything  herein to the  contrary,  in no event shall the Holder be permitted to
exercise this Warrant for a number of Shares  greater than the number that would
cause  the  aggregate   beneficial  ownership  of  the  Company's  Common  Stock
(calculated  pursuant to Rule 13d-3 of the  Securities  Exchange Act of 1934, as
amended) of (a) the Holder and its  affiliates or (b) Mercator  Advisory  Group,
LLC,  and its  affiliates,  to equal 9.99% of the  Company's  Common  Stock then
outstanding.

1.4  PROCEDURE  FOR  EXERCISE OF WARRANT.  Holder may  exercise  this Warrant by
delivering  the following to the  principal  office of the Company in accordance
with Section 5.1 hereof: (i) a duly executed Notice of Exercise in substantially
the form  attached  as Schedule  A, (ii)  payment of the  Warrant  Price then in
effect for each of the Shares being  purchased,  as  designated in the Notice of
Exercise,  and (iii) this Warrant.  Payment of the Warrant Price may be in cash,
certified or official  bank check  payable to the order of the Company,  or wire
transfer of funds to the  Company's  account (or any  combination  of any of the
foregoing) in the amount of the Warrant Price for each share being purchased.

1.5 DELIVERY OF CERTIFICATE AND NEW WARRANT. In the event of any exercise of the
rights represented by this Warrant, a certificate or certificates for the shares
of Common Stock so purchased, registered in the name of the Holder or such other
name or  names as may be  designated  by the  Holder,  together  with any  other
securities  or other  property  which the Holder is  entitled  to  receive  upon
exercise  of this  Warrant,  shall be  delivered  to the Holder  hereof,  at the
Company's expense, within a reasonable time, not exceeding fifteen (15) calendar
days, after the rights represented by this Warrant shall have been so exercised;
and, unless this Warrant has expired,  a new Warrant  representing the number of
Shares (except a remaining fractional share), if any, with respect to which this
Warrant  shall not then have been  exercised  shall also be issued to the Holder
hereof within such time. The person in whose name any  certificate for shares of
Common Stock is issued upon  exercise of this Warrant  shall for all purposes be
deemed to have  become the holder of record of such  shares on the date on which
the Warrant was surrendered and payment of the Warrant Price was received by the
Company, irrespective of the date of delivery of such certificate,  except that,
if the date of such  surrender and payment is on a date when the stock  transfer
books of the Company are closed,  such person shall be deemed to have become the
holder of such Shares at the close of business  on the next  succeeding  date on
which the stock transfer books are open.

1.6  RESTRICTIVE  LEGEND.  Each  certificate for Shares shall bear a restrictive
legend in substantially the form as follows, together with any additional legend
required by (i) any  applicable  state  securities  laws and (ii) any securities
exchange upon which such Shares may, at the time of such exercise, be listed:

      THE SHARES OF STOCK EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED
      UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE OFFERED,
      SOLD, PLEDGED OR OTHERWISE  TRANSFERRED  ("TRANSFERRED") IN THE ABSENCE OF
      SUCH REGISTRATION OR AN APPLICABLE EXEMPTION THEREFROM.  IN THE ABSENCE OF
      SUCH  REGISTRATION,  SUCH  SHARES MAY NOT BE  TRANSFERRED  UNLESS,  IF THE
      COMPANY REQUESTS,  THE COMPANY HAS RECEIVED A WRITTEN OPINION FROM COUNSEL
      IN FORM AND  SUBSTANCE  SATISFACTORY  TO THE  COMPANY  STATING  THAT  SUCH
      TRANSFER IS BEING MADE IN COMPLIANCE WITH ALL APPLICABLE FEDERAL AND STATE
      SECURITIES LAWS.

Any  certificate  issued  at any  time  in  exchange  or  substitution  for  any
certificate  bearing  such  legend  shall also bear such legend  unless,  in the
opinion of counsel for the Holder  thereof  (which  counsel  shall be reasonably
satisfactory  to the Company),  the securities  represented  thereby are not, at
such time, required by law to bear such legend.

1.7 FRACTIONAL  SHARES.  No fractional Shares shall be issuable upon exercise or
conversion of the Warrant. In the event of a fractional interest,  the number of
Shares to be issued shall be rounded down to the nearest whole Share.

                                     Page 1
<PAGE>

2. REPRESENTATIONS, WARRANTIES AND COVENANTS.

2.1 REPRESENTATIONS AND WARRANTIES.

      (a) The Company is a corporation  duly organized,  validly existing and in
good standing under the laws of its state of incorporation and has all necessary
power and authority to perform its obligations under this Warrant;

      (b) The execution,  delivery and performance of this Warrant has been duly
authorized by all necessary  actions on the part of the Company and  constitutes
the legal, valid and binding obligation of the Company,  enforceable against the
Company in accordance with its terms; and

      (c) This Warrant  does not violate and is not in conflict  with any of the
provisions  of  the  Company's  Articles  of  Incorporation  or  Certificate  of
Determination, Bylaws and any resolutions of the Company's Board of Directors or
stockholders,  or any agreement of the Company, and no event has occurred and no
condition or circumstance  exists that might (with or without notice or lapse of
time)  constitute  or result  directly  or  indirectly  in such a  violation  or
conflict.

2.2  ISSUANCE  OF SHARES.  The Company  covenants  and agrees that all shares of
Common Stock that may be issued upon the exercise of the rights  represented  by
this  Warrant  will,  upon  issuance,   be  validly   issued,   fully  paid  and
nonassessable,  and free from all taxes,  liens and charges  with respect to the
issue thereof.  The Company  further  covenants and agrees that it will pay when
due and  payable  any and all  federal  and state  taxes which may be payable in
respect  of the  issue of this  Warrant  or any  Common  Stock  or  certificates
therefor  issuable  upon the  exercise  of this  Warrant.  The  Company  further
covenants  and agrees that the  Company  will at all times have  authorized  and
reserved,  free from preemptive  rights, a sufficient number of shares of Common
Stock to provide  for the  exercise  in full of the rights  represented  by this
Warrant.  If at any time the number of authorized but unissued  shares of Common
Stock of the  Company  shall not be  sufficient  to effect the  exercise  of the
Warrant in full,  subject to the  limitations  set forth in Section  1.3 hereto,
then the Company will take all such  corporate  action as may, in the opinion of
counsel to the Company,  be necessary or advisable to increase the number of its
authorized  shares of Common Stock as shall be sufficient to permit the exercise
of the  Warrant in full,  subject to the  limitations  set forth in Section  1.3
hereto,  including  without  limitation,  using its best  efforts  to obtain any
necessary  stockholder  approval of such increase.  If and so long as the Common
Stock  issuable  upon the  exercise  of this  Warrant is listed on any  national
securities  exchange or the Nasdaq Stock Market,  the Company will, if permitted
by the rules of such  exchange or market,  list and keep listed on such exchange
or market,  upon  official  notice of issuance,  all shares of such Common Stock
issuable upon exercise of this Warrant.

3. OTHER ADJUSTMENTS.

3.1 SUBDIVISION OR COMBINATION OF SHARES.  In case the Company shall at any time
subdivide  its  outstanding  Common Stock into a greater  number of shares,  the
Warrant  Price  in  effect  immediately  prior  to  such  subdivision  shall  be
proportionately  reduced, and the number of Shares subject to this Warrant shall
be  proportionately  increased,  and conversely,  in case the outstanding Common
Stock of the Company  shall be  combined  into a smaller  number of shares,  the
Warrant  Price  in  effect  immediately  prior  to  such  combination  shall  be
proportionately  increased,  and the number of Shares  subject  to this  Warrant
shall be proportionately decreased.

3.2 DIVIDENDS IN COMMON STOCK,  OTHER STOCK OR PROPERTY.  If at any time or from
time to time the  holders  of  Common  Stock  (or any  shares  of stock or other
securities at the time  receivable upon the exercise of this Warrant) shall have
received or become entitled to receive, without payment therefor:

      (a) Common Stock,  Options or any shares or other  securities which are at
any time  directly or indirectly  convertible  into or  exchangeable  for Common
Stock, or any rights or options to subscribe for,  purchase or otherwise acquire
any of the foregoing by way of dividend or other distribution;

      (b) any cash paid or payable otherwise than as a regular cash dividend; or

      (c) Common  Stock or  additional  shares or other  securities  or property
(including cash) by way of spin-off, split-up, reclassification,  combination of
shares or similar corporate  rearrangement  (other than Common Stock issued as a
stock split or  adjustments in respect of which shall be covered by the terms of
Section 3.1 above) and additional shares, other securities or property issued in
connection with a Change (as defined below) (which shall be covered by the terms
of Section 3.4 below), then and in each such case, the Holder hereof shall, upon
the exercise of this Warrant,  be entitled to receive, in addition to the number
of shares of Common  Stock  receivable  thereupon,  and  without  payment of any
additional  consideration therefor, the amount of stock and other securities and
property  (including  cash in the cases referred to in clause (b) above and this
clause (c)) which such Holder  would hold on the date of such  exercise had such
Holder  been the holder of record of such  Common  Stock as of the date on which
holders of Common  Stock  received or became  entitled to receive such shares or
all other additional stock and other securities and property.

3.3  REORGANIZATION,  RECLASSIFICATION,  CONSOLIDATION,  MERGER OR SALE.  If any
recapitalization, reclassification or reorganization of the share capital of the
Company, or any consolidation or merger of the Company with another corporation,
or the sale of all or  substantially  all of its shares  and/or  assets or other
transaction (including,  without limitation,  a sale of substantially all of its
assets  followed by a liquidation)  shall be effected in such a way that holders
of Common Stock shall be entitled to receive shares,  securities or other assets
or property  (a  "Change"),  then,  as a condition  of such  Change,  lawful and
adequate provisions shall be made by the Company whereby the Holder hereof shall
thereafter  have the right to purchase  and receive (in lieu of the Common Stock
of the Company  immediately  theretofore  purchasable  and  receivable  upon the
exercise of the rights  represented  hereby)  such shares,  securities  or other
assets or  property as may be issued or payable  with  respect to or in exchange
for the number of  outstanding  Common  Stock which such Holder  would have been
entitled to receive had such Holder exercised this Warrant  immediately prior to
the  consummation  of such Change.  The Company or its successor  shall promptly
issue to Holder a new Warrant for such new securities or other property. The new
Warrant shall provide for adjustments which shall be as nearly equivalent as may
be practicable to give effect to the adjustments  provided for in this Section 3
including,  without  limitation,  adjustments  to the  Warrant  Price and to the
number of securities or property issuable upon exercise of the new Warrant.  The
provisions of this Section 3.3 shall similarly apply to successive Changes.

4. OWNERSHIP AND TRANSFER.

4.1  OWNERSHIP  OF THIS  WARRANT.  The  Company may deem and treat the person in
whose  name  this  Warrant  is   registered  as  the  holder  and  owner  hereof
(notwithstanding  any  notations of  ownership or writing  hereon made by anyone
other than the Company) for all purposes and shall not be affected by any notice
to the contrary until  presentation of this Warrant for registration of transfer
as provided in this Section 4.

4.2 TRANSFER AND REPLACEMENT.  Subject to restrictions on transferability  under
applicable   securities   laws,  this  Warrant  and  all  rights  hereunder  are
transferable  in whole or in part upon the books of the  Company  by the  Holder
hereof in person or by duly authorized attorney,  and a new Warrant or Warrants,
of the same tenor as this Warrant but  registered in the name of the  transferee
or  transferees  (and in the  name  of the  Holder,  if a  partial  transfer  is
effected)  shall be made and  delivered  by the Company  upon  surrender of this
Warrant duly endorsed,  at the office of the Company in accordance  with Section
5.1 hereof. Upon receipt by the Company of evidence  reasonably  satisfactory to
it of the loss,  theft or  destruction,  and,  in such  case,  of  indemnity  or
security  reasonably  satisfactory  to it, and upon surrender of this Warrant if
mutilated,  the Company  will make and  deliver a new Warrant of like tenor,  in
lieu of this Warrant;  provided that if the Holder hereof is an  instrumentality
of a state or local government or an institutional  holder or a nominee for such
an instrumentality or institutional holder an irrevocable agreement of indemnity
by such Holder  shall be  sufficient  for all purposes of this  Warrant,  and no
evidence of loss or theft or destruction shall be necessary.  This Warrant shall
be promptly  cancelled by the Company upon the  surrender  hereof in  connection
with any transfer or  replacement.  Except as otherwise  provided  above, in the
case of the loss,  theft or destruction of a Warrant,  the Company shall pay all
expenses,  taxes and other charges  payable in  connection  with any transfer or
replacement  of this Warrant,  other than income taxes and stock  transfer taxes
(if any) payable in connection  with a transfer of this Warrant,  which shall be
payable by the Holder.  Holder  will not  transfer  this  Warrant and the rights
hereunder except in compliance with federal and state securities laws and except
after  providing  evidence of such  compliance  reasonably  satisfactory  to the
Company.

                                     Page 2
<PAGE>

5. MISCELLANEOUS PROVISIONS.

5.1 NOTICES.  Any notice or other document  required or permitted to be given or
delivered  to the Holder  shall be  delivered  or forwarded to the Holder at c/o
Mercator Advisory Group, LLC, 555 South Flower Street,  Suite 4200, Los Angeles,
California 90071, Attention: David F. Firestone (Facsimile No. 213/553-8285), or
to such other  address or number as shall have been  furnished to the Company in
writing by the Holder, with a copy to Sheppard Mullin Richter & Hampton LLP, 333
South Hope Street,  48th Floor,  Los Angeles,  California  90071-1448  Attention
David C.  Ulich  (Facsimile  No.  213/620-1398).  Any  notice or other  document
required or permitted to be given or delivered to the Company shall be delivered
or forwarded to the Company at GeneThera,  Inc., 3930 Youngfield  Street,  Wheat
Ridge, Colorado 80033, Attention:  Antonio Milici (Facsimile No. (303) 463-6377)
with a copy to Kendall,  Koenig & Oelsner PC, 1675 Broadway,  Suite 750, Denver,
CO 80202 Attention:  Nathan E. Seiler (Facsimile No. (303) 672-0101), or to such
other address or number as shall have been furnished to Holder in writing by the
Company.

5.2 All notices,  requests and  approvals  required by this Warrant  shall be in
writing and shall be conclusively  deemed to be given (i) when hand-delivered to
the other  party,  (ii) when  received if sent by  facsimile  at the address and
number set forth above;  provided that notices  given by facsimile  shall not be
effective,  unless  either  (a) a  duplicate  copy of such  facsimile  notice is
promptly given by depositing the same in the mail, postage prepaid and addressed
to the party as set forth below or (b) the  receiving  party  delivers a written
confirmation of receipt for such notice by any other method permitted under this
paragraph;  and further  provided  that any notice given by  facsimile  received
after  5:00 p.m.  (recipient's  time) or on a  non-business  day shall be deemed
received on the next business day; (iii) five (5) business days after deposit in
the United States mail,  certified,  return receipt requested,  postage prepaid,
and  addressed  to the party as set forth below;  or (iv) the next  business day
after deposit with an international overnight delivery service, postage prepaid,
addressed  to the  party as set forth  below  with next  business  day  delivery
guaranteed;  provided that the sending party receives  confirmation  of delivery
from the delivery service provider.

5.3 NO RIGHTS AS  SHAREHOLDER;  LIMITATION OF LIABILITY.  This Warrant shall not
entitle the Holder to any of the rights of a shareholder  of the Company  except
upon exercise in accordance with the terms hereof.  No provision  hereof, in the
absence of affirmative  action by the Holder to purchase shares of Common Stock,
and no mere enumeration herein of the rights or privileges of the Holder,  shall
give rise to any liability of the Holder for the Warrant Price hereunder or as a
shareholder of the Company, whether such liability is asserted by the Company or
by creditors of the Company.

5.4 GOVERNING LAW. This Warrant shall be governed by and construed in accordance
with  the  laws of the  State of  California  as  applied  to  agreements  among
California  residents  made and to be  performed  entirely  within  the State of
California, without giving effect to the conflict of law principles thereof.

5.5  BINDING  EFFECT ON  SUCCESSORS.  This  Warrant  shall be  binding  upon any
corporation  succeeding the Company by merger,  consolidation  or acquisition of
all or substantially all of the Company's assets and/or  securities.  All of the
obligations of the Company  relating to the Shares issuable upon the exercise of
this Warrant shall survive the exercise and termination of this Warrant.  All of
the  covenants  and  agreements of the Company shall inure to the benefit of the
successors and assigns of the Holder.

5.6 WAIVER,  AMENDMENTS AND HEADINGS.  This Warrant and any provision hereof may
be changed,  waived,  discharged or terminated  only by an instrument in writing
signed by both parties (either generally or in a particular  instance and either
retroactively or  prospectively).  The headings in this Warrant are for purposes
of reference only and shall not affect the meaning or construction of any of the
provisions hereof.

5.7 JURISDICTION.  Each of the parties irrevocably agrees that any and all suits
or  proceedings  based on or arising under this Agreement may be brought only in
and shall be resolved in the federal or state courts  located in the City of Los
Angeles,  California  and consents to the  jurisdiction  of such courts for such
purpose.  Each of the parties  irrevocably waives the defense of an inconvenient
forum to the  maintenance of such suit or proceeding in any such court.  Each of
the parties  further  agrees that  service of process  upon such party mailed by
first  class mail to the  address  set forth in  Section  5.1 shall be deemed in
every respect  effective  service of process upon such party in any such suit or
proceeding.  Nothing  herein  shall  affect  the right of either  party to serve
process in any other manner  permitted by law. Each of the parties agrees that a
final non-appealable judgment in any such suit or proceeding shall be conclusive
and may be enforced in other  jurisdictions  by suit on such  judgment or in any
other lawful manner.

5.8  ATTORNEYS'  FEES AND  DISBURSEMENTS.  If any  action at law or in equity is
necessary to enforce or interpret the terms of this  Agreement,  the  prevailing
party or parties  shall be entitled  to receive  from the other party or parties
reasonable  attorneys' fees and disbursements in addition to any other relief to
which the prevailing party or parties may be entitled.

                                     Page 3
<PAGE>

IN WITNESS WHEREOF, the Company has caused this Warrant to be signed by its duly
authorized officer this 18th day of January, 2005.

COMPANY:
                                                    GENETHERA, INC.

                                                    BY /S/ ANTONIO MILICI

                                                    PRINT NAME:  ANTONIO MILICI

                                                    TITLE: CHAIRMAN AND CEO

                                     Page 4
<PAGE>

                                   SCHEDULE A

                           FORM OF NOTICE OF EXERCISE

                [TO BE SIGNED ONLY UPON EXERCISE OF THE WARRANT]

                     TO BE EXECUTED BY THE REGISTERED HOLDER
                         TO EXERCISE THE WITHIN WARRANT

The  undersigned  hereby elects to purchase  _______ shares of Common Stock (the
"Shares") of GeneThera,  Inc.  under the Warrant to Purchase  Common Stock dated
January __ , 2005, which the undersigned is entitled to purchase pursuant to the
terms of such Warrant. The undersigned has delivered  $_________,  the aggregate
Warrant  Price  for  _____  Shares  purchased  herewith,  in  full in cash or by
certified or official bank check or wire transfer.

      Please issue a certificate  or  certificates  representing  such shares of
Common  Stock  in the  name  of the  undersigned  or in  such  other  name as is
specified below and in the denominations as is set forth below:

        ________________________________________________________________________
        [Type Name of Holder as it should appear on the stock certificate]

        ________________________________________________________________________
        [Requested Denominations - if no denomination is specified, a single
        certificate will be issued]

      The  initial  address of such Holder to be entered on the books of Company
shall be:

        ________________________________________________________________________

        ________________________________________________________________________

        ________________________________________________________________________

      The  undersigned  hereby  represents and warrants that the  undersigned is
acquiring such shares for his own account for investment  purposes only, and not
for resale or with a view to distribution of such shares or any part thereof.

                                    By:
                                       -----------------------------------------

                                    Print Name:
                                               ---------------------------------

                                    Title:
                                          --------------------------------------

                                    Dated:
                                          --------------------------------------

                                     Page 5
<PAGE>

                               FORM OF ASSIGNMENT
                                    (ENTIRE)

               [TO BE SIGNED ONLY UPON TRANSFER OF ENTIRE WARRANT]

                     TO BE EXECUTED BY THE REGISTERED HOLDER
                         TO TRANSFER THE WITHIN WARRANT

FOR  VALUE  RECEIVED   ___________________________  hereby  sells,  assigns  and
transfers  unto  _______________________________  all rights of the  undersigned
under and  pursuant  to the within  Warrant,  and the  undersigned  does  hereby
irrevocably  constitute and appoint  _____________________  Attorney to transfer
the said  Warrant  on the  books  of  ________  _________,  with  full  power of
substitution.

_______________________________________
[Type Name of Holder]

By: ___________________________________

Title:_________________________________

Dated:_________________________________

NOTICE

The signature to the foregoing Assignment must correspond exactly to the name as
written upon the face of the within Warrant,  without  alteration or enlargement
or any change whatsoever.

                                       -1-
<PAGE>

                               FORM OF ASSIGNMENT
                                    (PARTIAL)

              [TO BE SIGNED ONLY UPON PARTIAL TRANSFER OF WARRANT]

                     TO BE EXECUTED BY THE REGISTERED HOLDER
                         TO TRANSFER THE WITHIN WARRANT

FOR  VALUE  RECEIVED   ___________________________  hereby  sells,  assigns  and
transfers unto ____________________________ (i) the rights of the undersigned to
purchase  ____________________  shares of Common Stock under and pursuant to the
within  Warrant,  and (ii) on a  non-exclusive  basis,  all other  rights of the
undersigned  under and pursuant to the within Warrant,  it being understood that
the undersigned shall retain, severally (and not jointly) with the transferee(s)
named herein, all rights assigned on such  non-exclusive  basis. The undersigned
does  hereby  irrevocably  constitute  and  appoint   __________________________
Attorney to transfer  the said  Warrant on the books of  GeneThera , Inc.,  with
full power of substitution.

[Type Name of Holder]

By:
     ------------------------------------------
Title:
     ------------------------------------------

Dated:
        ---------------------------------------

NOTICE

The signature to the foregoing Assignment must correspond exactly to the name as
written upon the face of the within Warrant,  without  alteration or enlargement
or any change whatsoever.

                                       -2-VITROTECH CORPORATION

                           2004 CONSULTANT STOCK PLAN
                          (as amended January 14, 2005)

                                 PURPOSE OF PLAN

      WHEREAS, the purpose of this 2004 Consultant Stock Plan is to advance the
interests of the Company by helping the Company obtain and retain the services
of persons providing consulting services upon whose judgment, initiative,
efforts and/or services the Company is substantially dependent, by offering to
or providing those persons with incentives or inducements affording such persons
an opportunity to become owners of capital stock of the Company.

                          TERMS AND CONDITIONS OF PLAN

      1. DEFINITIONS.

      Set forth below are definitions of capitalized terms that are generally
used throughout this Plan, or references to provisions containing such
definitions (capitalized terms whose use is limited to specific provisions are
not referenced in this Section):

            (A) AFFILIATE - The term "Affiliate" is defined as any person
controlling the Company, controlled by the Company, or under common control with
the Company.

            (B) AWARD - The term "Award" is collectively and severally defined
as any Award Shares granted under this Plan.

            (C) AWARD SHARES - The term "Award Shares" is defined as shares of
Common Stock granted by the Plan Committee in accordance with Section 5 of this
Plan.

            (D) BOARD - The term "Board" is defined as the Board of Directors of
the Company, as such body may be reconstituted from time to time.

            (E) COMMON STOCK - The term "Common Stock" is defined as the
Company's common stock, $.001 par value.

            (F) COMPANY - The term "Company" is defined as VitroTech
Corporation, a Nevada corporation.

<PAGE>

      (G) DISPOSED - The term "Disposed" (or the equivalent terms "Disposition"
or "Dispose") is defined as any transfer or alienation of an Award which would
directly or indirectly change the legal or beneficial ownership thereof, whether
voluntary or by operation of law, or with or without the payment or provision of
consideration, including, by way of example and not limitation: (i) the sale,
assignment, bequest or gift of the Award; (ii) any transaction that creates or
grants a right to obtain an interest in the Award; (iii) any transaction that
creates a form of joint ownership in the Award between the Recipient and one or
more other Persons; (iv) any Disposition of the Award to a creditor of the
Recipient, including the hypothecation, encumbrance or pledge of the Award or
any interest therein, or the attachment or imposition of a lien by a creditor of
the Recipient of the Award or any interest therein which is not released within
thirty (30) days after the imposition thereof; (v) any distribution by a
Recipient which is an entity to its stockholders, partners, co-venturers or
members, as the case may be, or (vi) any distribution by a Recipient which is a
fiduciary such as a trustee or custodian to its settlors or beneficiaries.

      (H) ELIGIBLE PERSON - The term "Eligible Person" means any Person who, at
a particular time, is a consultant to the Company or an Affiliate who provides
bona fide consulting services to the Company or the Affiliate, provided,
however, no Award hereunder may be granted to any Person in connection with the
provision of any services incident to the raising of capital or promotion or
maintenance of a market for the Company's securities.

      (I) FAIR MARKET VALUE - The term "Fair Market Value" means the fair market
value as of the applicable valuation date of the Award Shares, or other shares
of Common Stock, as the case may be (the "Subject Shares"), to be valued as
determined by the Plan Committee in its good faith judgment, but in no event
shall the Fair Market Value be less than the par value of the Subject Shares.

      (J) PERSON - The term "Person" is defined, in its broadest sense, as any
individual, entity or fiduciary such as, by way of example and not limitation,
individual or natural persons, corporations, partnerships (limited or general),
joint-ventures, associations, limited liability companies/partnerships, or
fiduciary arrangements, such as trusts.

      (K) PLAN - The term "Plan" is defined as this 2004 Consultant Stock Plan,
as amended from time to time.

      (L) PLAN COMMITTEE - The term "Plan Committee" is defined as that
Committee appointed by the Board to administer and interpret this Plan as more
particularly described in Section 3 of the Plan; provided, however, that the
term Plan Committee will refer to the Board during such times as no Plan
Committee is appointed by the Board.

      (M) RECIPIENT - The term "Recipient" is defined as any Eligible Person
who, at a particular time, receives the grant of an Award.

      (N) SECURITIES ACT - The term "Securities Act" is defined as the
Securities Act of 1933, as amended (references herein to Sections of the
Securities Act are intended to refer to Sections of the Securities Act as
enacted at the time of the adoption of this Plan by the Board and as
subsequently amended, or to any substantially similar successor provisions of
the Securities Act resulting from recodification, renumbering or otherwise).

                                       2
<PAGE>
      2. TERM OF PLAN.

      This Plan shall be effective as of such time and date as this Plan is
adopted by the Board, and this Plan shall terminate on the first business day
prior to the ten (10) year anniversary of the date this Plan became effective.
All Awards granted pursuant to this Plan prior to the effective date of this
Plan shall not be affected by the termination of this Plan and all other
provisions of this Plan shall remain in effect until the terms of all
outstanding Awards have been satisfied or terminated in accordance with this
Plan and the terms of such Awards.

      3. PLAN ADMINISTRATION.

            (A) PLAN COMMITTEE.

                  (i) The Plan shall be administered and interpreted by a
            committee consisting of one (1) or more members of the Board;
            provided, however, no member of the Board may serve as a member of
            the Plan Committee if such person serves or served as a member of
            the plan committee with respect to any plan (other than this Plan)
            of the Company or its Affiliates which plan was or is established to
            comply with the provisions of Rule 16b-3(c)(2)(i) to the Securities
            and Exchange Act of 1934, as amended (i.e., pertaining to the
            establishment of so-called "Section 16b-3 Plans"), and, by reason of
            such person's proposed service as a member of the Plan Committee,
            such person would not be considered a "disinterested" person within
            the meaning of said Rule with respect to such other plan.

                  (ii) Members of the Plan Committee may resign at any time by
            delivering written notice to the Board. Vacancies in the Plan
            Committee shall be filled by the Board. The Plan Committee shall act
            by a majority of its members in office. The Plan Committee may act
            either by vote at a meeting or by a memorandum or other written
            instrument signed by a majority of the Plan Committee.

                  (iii) If the Board, in its discretion, does not appoint a Plan
            Committee, the Board itself will administer and interpret the Plan
            and take such other actions as the Plan Committee is authorized to
            take hereunder; provided that the Board may take such actions
            hereunder in the same manner as the Board may take other actions
            under the Articles of Incorporation and bylaws of the Company
            generally.

            (B) ELIGIBILITY OF PLAN COMMITTEE MEMBERS TO RECEIVE AWARDS. While
serving on the Plan Committee, such members shall not be eligible for selection
as Eligible Persons to whom an Award may be granted under the Plan.

            (C) POWER TO MAKE AWARDS. The Plan Committee shall have the full and
final authority in its sole discretion, at any time and from time-to-time,
subject only to the express terms, conditions and other provisions of the
Articles of Incorporation of the Company and this Plan, and the specific
limitations on such discretion set forth herein, to:

                                       3
<PAGE>

            (i) Designate the Eligible Persons or classes of Eligible Persons
      eligible to receive Awards from among the Eligible Persons;

                  (ii) Grant Awards to such selected Eligible Persons or classes
            of Eligible Persons in such form and amount (subject to the terms of
            the Plan) as the Plan Committee shall determine;

                  (iii) Interpret the Plan, adopt, amend and rescind rules and
            regulations relating to the Plan, and make all other determinations
            and take all other action necessary or advisable for the
            implementation and administration of the Plan; and

                  (iiii) Delegate all or a portion of its authority under
            subsections (i) and (ii) of this Section 3(c) to one or more
            directors of the Company who are executive officers of the Company,
            subject to such restrictions and limitations (such as the aggregate
            number of shares of Common Stock that may be awarded) as the Plan
            Committee may decide to impose on such delegate directors.

      In determining the recipient, form and amount of Awards, the Plan
Committee shall consider any factors deemed relevant, including the recipient's
functions, responsibilities, value of services to the Company and past and
potential contributions to the Company's profitability and sound growth.

            (D) INTERPRETATION OF PLAN. The Plan Committee shall, in its sole
and absolute discretion, interpret and determine the effect of all matters and
questions relating to this Plan. The interpretations and determinations of the
Plan Committee under the Plan (including without limitation determinations
pertaining to the eligibility of Persons to receive Awards, the form, amount and
timing of Awards, the methods of payment for Awards, and the other terms and
provisions of Awards and the certificates or agreements evidencing same) need
not be uniform and may be made by the Plan Committee selectively among Persons
who receive, or are eligible to receive, Awards under the Plan, whether or not
such Persons are similarly situated. All actions taken and all interpretations
and determinations made under this Plan in good faith by the Plan Committee
shall be final and binding upon the Recipient, the Company, and all other
interested Persons. No member of the Plan Committee shall be personally liable
for any action taken or decision made in good faith relating to this Plan, and
all members of the Plan Committee shall be fully protected and indemnified to
the fullest extent permitted under applicable law by the Company in respect to
any such action, determination, or interpretation.

            (E) COMPENSATION; ADVISORS. Members of the Plan Committee shall
receive such compensation for their services as members as may be determined by
the Board. All expenses and liabilities incurred by members of the Plan
Committee in connection with the administration of the Plan shall be borne by
the Company. The Plan Committee may, with the approval of the Board, employ
attorneys, consultants, accountants, appraisers, brokers, or other Persons, at
the cost of the Company. The Plan Committee, the Company and its officers and
directors shall be entitled to rely upon the advice, opinions, or valuations of
any such Persons.

                                       4
<PAGE>

      4. STOCK POOL.

            (A) MAXIMUM NUMBER OF SHARES AUTHORIZED UNDER PLAN. Shares of stock
which may be issued or granted under the Plan shall be authorized and unissued
or treasury shares of Common Stock. The aggregate maximum number of shares of
Common Stock which may be issued as a grant of Award Shares shall not exceed
7,000,000 shares of Common Stock (the "Stock Pool").

            (B) DATE OF AWARD. The date an Award is granted shall mean the date
selected by the Plan Committee as of which the Plan Committee allots a specific
number of shares to a Recipient with respect to such Award pursuant to the Plan.

      5. AWARD SHARES.

            (A) GRANT. The Plan Committee may from time to time, and subject to
the provisions of the Plan and such other terms and conditions as the Plan
Committee may prescribe, grant to any Eligible Person one or more shares of
Common Stock ("Award Shares") allotted by the Plan Committee. The grant of Award
Shares or grant of the right to receive Award Shares shall be evidenced by
either a written consulting agreement or a separate written agreement confirming
such grant, executed by the Company and the Recipient, stating the number of
Award Shares granted and stating all terms and conditions of such grant.

            (B) PURCHASE PRICE AND MANNER OF PAYMENT. The Plan Committee, in its
sole discretion, may grant Award Shares in any of the following instances:

                  (i) as a "bonus" or "reward" for services previously rendered
            and compensated, in which case the recipient of the Award Shares
            shall not be required to pay any consideration for such Award
            Shares, and the value of such Award Shares shall be the Fair Market
            Value of such Award Shares on the date of grant; or

                  (ii) as "compensation" for the previous performance or future
            performance of services or attainment of goals, in which case the
            recipient of the Award Shares shall not be required to pay any
            consideration for such Award Shares (other than the performance of
            his services).

      6. ADJUSTMENTS.

            (A) SUBDIVISION OR STOCK DIVIDEND. If (i) outstanding shares of
Common Stock shall be subdivided into a greater number of shares by reason of
recapitalization or reclassification, the number of shares of Common Stock, if
any, available for issuance in the Stock Pool shall, simultaneously with the
effectiveness of such subdivision or immediately after the record date of such
dividend, be proportionately increased, and (ii) conversely, if the outstanding
shares of Common Stock shall be combined into a smaller number of shares, the
number of shares of Common Stock, if any, available for issuance in the Stock
Pool shall, simultaneously with the effectiveness of such combination, be
proportionately increased.

                                       5
<PAGE>

            (B) ADJUSTMENTS DETERMINED IN SOLE DISCRETION OF BOARD. To the
extent that the foregoing adjustments relate to stock or securities of the
Company, such adjustments shall be made by the Plan Committee, whose
determination in that respect shall be final, binding and conclusive.

            (C) NO OTHER RIGHTS TO RECIPIENT. Except as expressly provided in
this Section 6, (i) the Recipient shall have no rights by reason of any
subdivision or consolidation of shares of stock of any class or the payment of
any stock dividend or any other increase or decrease in the number of shares of
stock of any class, and (ii) the dissolution, liquidation, merger, consolidation
or divisive reorganization or sale of assets or stock to another corporation, or
any issue by the Company of shares of stock of any class, or securities
convertible into shares of stock of any class, shall not affect, and no
adjustment by reason thereof shall be made with respect to, the number of
shares. The grant of an Award pursuant to this Plan shall not affect in any way
the right or power of the Company to make adjustments, reclassifications,
reorganizations or changes of its capital or business structure or to merge,
consolidate, dissolve or liquidate, or to sell or transfer all or any part of
its business or assets.

      7. EMPLOYMENT STATUS.

      In no event shall the granting of an Award be construed as granting a
continued right of employment to a Recipient if such Person is employed by the
Company, nor effect any right which the Company may have to terminate the
employment of such Person, at any time, with or without cause, except to the
extent that such Person and the Company have agreed otherwise in writing.

      8. AMENDMENT AND DISCONTINUATION OF PLAN; MODIFICATION OF AWARDS.

            (A) AMENDMENT, MODIFICATION OR TERMINATION OF PLAN. The Board may
amend the Plan or suspend or discontinue the Plan at any time or from
time-to-time; provided, however no such action may adversely alter or impair any
Award previously granted under this Plan without the consent of each Recipient
affected thereby.

            (B) COMPLIANCE WITH LAWS. The Plan Committee may at any time or from
time-to-time, without receiving further consideration from any Person who may
become entitled to receive or who has received the grant of an Award hereunder,
modify or amend Awards granted under this Plan as required to comply with
changes in securities, tax or other laws or rules, regulations or regulatory
interpretations thereof applicable to this Plan or Awards thereunder or to
comply with stock exchange rules or requirements.

                                       6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00077-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00077-of-00352.parquet"}]]